Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Enable Injections Inc. currently has 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed among 3 distinct examiners, providing a variety of examiner interactions for the company. However, all 3 pending actions are located within 1 distinct art unit, which indicates that the technology is being evaluated under a consistent set of departmental standards despite the different individuals involved in the review process.
The busiest examiner for the portfolio is FREHE, WILLIAM R, who is currently handling 1 pending office action. With 3 pending actions in total, the workload is evenly split among the 3 examiners involved. This situation allows the applicant to experience different examiner perspectives while remaining within 1 art unit, potentially offering insights into how different individuals within the same unit interpret the company's medical device technology. The concentration in a single art unit suggests a focused technical classification for these 3 matters.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FREHE, WILLIAM R | 1 | 59.9% | +42.5% |
| RADOMSKI, MARTIN ADAM | 1 | 32.3% | +55.7% |
| SCHMIDT, EMILY LOUISE | 1 | 58.4% | +36.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16923612 | MEDICAL VIAL AND INJECTOR ASSEMBLIES AND METHODS OF USE | SCHMIDT, EMILY LOUISE | 86d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16923612 | MEDICAL VIAL AND INJECTOR ASSEMBLIES AND METHODS OF USE | SCHMIDT, EMILY LOUISE | 86d overdue |
| 18069858 | MEDICAL FLUID INJECTION APPARATUS AND METHOD WITH REUSABLE PATCH | RADOMSKI, MARTIN ADAM | 8d |
| 18456737 | MEDICAL FLUID INJECTION APPARATUS AND METHOD WITH DETACHABLE PATCH AND MONITORING | FREHE, WILLIAM R | — |
| Art Unit | Apps |
|---|---|
| 3783 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18456737 | MEDICAL FLUID INJECTION APPARATUS AND METHOD WITH DETACHABLE PATCH AND MONITORING | FREHE, WILLIAM R | 3783 | §103 | Final Rejection | — | Pending | Aug 28, 2023 |
| 18069858 | MEDICAL FLUID INJECTION APPARATUS AND METHOD WITH REUSABLE PATCH | RADOMSKI, MARTIN ADAM | 3783 | §103 | Final Rejection | 8d | Pending | Dec 21, 2022 |
| 16923612 | MEDICAL VIAL AND INJECTOR ASSEMBLIES AND METHODS OF USE | SCHMIDT, EMILY LOUISE | 3783 | §103§112 | Non-Final OA | 86d overdue | Pending | Jul 08, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial